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Background: Ensuring high quality care for persons with diabetes remains a challenge for healthcare systems
globally with consistent evidence of suboptimal care and outcomes. There is increasing interest in quality
improvement strategies to improve diabetes management as reflected by a growing number of systematic reviews.
These reviews are of varying quality and dispersed across many sources. In this paper, we present an overview of
systematic reviews evaluating the impact of interventions to improve the quality of diabetes care.
Methods: We searched for systematic reviews evaluating the effectiveness of any intervention intended to improve
intermediate patient outcomes and process of care measures for patients with any type of diabetes. Two reviewers
independently screened search results, appraised each systematic review using AMSTAR and extracted data from
high quality reviews (AMSTAR score ≥ 5). Within reviews, we used vote counting by direction of effect to report the
number of studies favouring an intervention for each outcome. We produced summaries of results for each
intervention category.
Results: We identified 125 reviews of varying methodological quality and summarised key findings from 50 high
quality reviews. We categorised reviews by quality improvement intervention. Eight reviews were broad based
(involving a variety of strategies). Other reviews considered: patient education and support (n = 21), telemedicine
(n = 10), provider role changes (n = 7), and organisational changes (n = 4). Reviews reported intermediate patient
outcomes (e.g. glycaemic control) (n = 49) and process of care outcomes (n = 9). There was evidence of
considerable overlap of included studies between reviews.
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Conclusions: There is consistent evidence from high quality systematic reviews that patient education and support,
provider role changes, and telemedicine are associated with improvements in glycaemic and vascular risk factor
control in patients. There is less evidence about the impact of quality improvement interventions on other key
process measures such as screening patients for diabetic complications. This paper provides decision makers with a
comprehensive overview of evidence from high quality systematic reviews about the effects of quality
improvement interventions on improving diabetes care.
Keywords: Diabetes mellitus, Quality assurance, Health care, Quality improvement, Evidence-based practice,
Evidence-based medicine, Overview of systematic reviews, Diabetes management, Intervention strategiesBackground
Diabetes is a complex health problem that results in
significant morbidity and mortality and health care
resource utilisation [1-3]. With projected increases in
the incidence of diabetes worldwide, health systems
continue to focus on improving and optimising diabetes
care by influencing patient behaviour and improving
efficiency of care [1-3]. Yet, providing high quality care
for diabetics still remains a challenge for healthcare
systems and providers.
Recognising that gaps exist between best and actual
care, researchers, people with diabetes, clinicians and
decision makers have shown an increasing interest in
quality improvement (QI) strategies to improve diabetes
management [4]. Quality improvement strategies are
‘multidisciplinary, systems-focused, data-driven methods
of understanding and improving the efficiency, effective-
ness, and reliability of health process and outcomes of
care’. QI strategies attempt to ‘reduce the difference
between health care processes or outcomes observed in
practice and those potentially obtainable based on current
evidence-based knowledge’ [5].
There is substantial evidence and consensus on what
constitutes high quality diabetes care [6]. Despite this,
suboptimal care and poor patient outcomes continue at
the local, national and international level [7]. For example,
In Canada, evidence-based clinical practice guidelines for
the management of diabetes have been available since
1998 [8]. While these guidelines have contributed to
improvements in care [8-10], Ontario diabetes patients
are still not optimally managed [9]. For example, between
2005 and 2008 the proportion of diabetes patients who
had annual eye exams or foot exams remained fairly static
at approximately 51% [9]. Further, only 46% of elderly
diabetic patients in Ontario filled prescriptions for both
ACE inhibitors and statins despite recommendations that
most diabetes patients should receive both [8,11,12].
The current interest in QI interventions to improve
diabetes care has led to a profusion of primary studies
on diabetes that is overwhelming. Whilst systematic
reviews partly address this problem of information over-
load, decision makers often find it difficult to reliablyretrieve and keep up to date with the growing volume of
published systematic reviews [13]. In addition, available
systematic reviews are of variable quality, complexity
and length, and are published in a variety of sources
[14]. Further synthesis of this evidence is needed to pro-
vide reliable and accessible information to clinicians and
decision makers. Overviews of systematic reviews are an
efficient way to gather the best available evidence in a
single source to provide broad, cumulative statements
that summarise the current evidence on the effectiveness
of interventions. Such overviews are helpful as starting
points for decision makers to unpack the evidence
towards finding solutions to improving practice and
identify areas where new research is needed. This paper




We included systematic reviews that evaluated interven-
tions to improve the quality of diabetes care and manage-
ment in patients of any age, with any type of diabetes, in
any setting compared to usual care or other intervention(s).
We defined a systematic review as a synthesis of research
evidence in which literature searches, inclusion criteria,
and critical appraisal methods were explicitly described.
We excluded primary studies, and systematic reviews
that addressed multiple chronic diseases where it was
not possible to isolate the effects of QI interventions on
diabetes care.
To be included, systematic reviews had to report
effects on at least one intermediate patient outcome,
(glycaemic control as measured by glycated haemoglobin
(HbA1c) level. vascular risk factor control as measured
by high-density lipoprotein, total cholesterol, or blood
pressure levels, or maintaining smoking cessation for at
least one year) or process of care measure (monitoring
HbA1c levels in patients, prescribing appropriate me-
dications such as acetylsalicylic acid, statins, or anti-
hypertensive drugs to control vascular risks, conducting
retinopathy screening or referring patients for eye exami-
nations, performing foot examinations to screen patients
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monitoring renal function through testing of creatinine or
microalbumin, or prescribing nicotine replacement thera-
pies to promote smoking cessation). We excluded syste-
matic reviews that only reported changes in knowledge or
attitudes towards treatment of diabetes [15].
Search strategy to identify systematic reviews
We searched the following electronic databases without
language restrictions: Medline, EMBASE, AARP Ageline,
AMED (Allied and Complementary Medicine), and
HealthSTAR via OVID, The Cochrane Database of
Systematic Reviews and DARE (Database of Abstracts
and Reviews) via Wiley, Health Systems Evidence (www.
healthsystemsevidence.org/), Rx for Change (www.
rxforchange.ca/), and Google.
We used two search strategies to identify potentially eli-
gible systematic reviews. The strategies are based on those
used by Shojania [16,17] and the Cochrane Effective Prac-
tice and Organisation of Care (EPOC) Group. Full details
of the searches and rationale are provided in Additional
file 1. Search dates spanned 1976 to April 2011.
Selection
Two reviewers independently screened all titles and
abstracts identified by the searches. We retrieved the full
papers of citations that passed the initial screening, and
two reviewers independently assessed each against the
eligibility criteria. Reviewers compared results and re-
solved any discrepancies through discussion or third party
adjudication.
Quality assessment
Two reviewers independently assessed the methodological
quality of all reviews that met the eligibility criteria using
the ‘assessment of multiple systematic reviews’ (AMSTAR)
checklist [18,19], an 11-item validated measurement tool
where reviewers score one point for each criterion met,
with higher scores indicating a higher level of methodo-
logical quality. Items on the AMSTAR checklist assess
criteria such as the comprehensiveness of the search and
whether the quality of included studies was evaluated and
accounted for [20]. Reviewers compared scores for each
item of the AMSTAR checklist and resolved disagree-
ments through discussion or third party adjudication. To
present the best available evidence, we extracted data from
those systematic reviews that scored five or above [20].
Data extraction
Two reviewers independently extracted data from each in-
cluded systematic review using standard forms developed
for this overview. We used a consensus process to ensure
the consistency and reliability of the data and enlisted the
assistance of a third party in cases of disagreement. Foreach included systematic review, we extracted review level
information on the objectives, publication year, number of
included studies, search dates, country of origin, method(s)
of analysis used, as well as relevant quantitative data such
as pooled effect sizes. We did not retrieve primary study
publications; rather we abstracted primary study data
reported within each systematic review on study design,
population, intervention(s), comparator, and direction of
effect, whether reported descriptively or numerically. We
classified the interventions used in each study using the
McMaster Health Forum taxonomy [21].
Analysis
At the review level, we categorized each systematic review
by quality improvement category (Additional file 2). We
analysed, summarised, and reported separately the results
of all relevant comparisons within each systematic review
using quantitative and qualitative methods as appropriate.
We used vote counting as our method of analysis [22].
We counted the number of studies showing a positive
direction of effect. If the review reported conflicting
results or we were not able to determine the direction of
effect, we classified the outcome as unclear. We excluded
studies from our analysis that were beyond the scope of
this project and reported this for each review.
We considered the results of the intervention effects
featured in reviews when five or more of the included
studies reported on a given outcome. We determined an
intervention to be generally effective when the results of
67% or more of the included studies favoured the inter-
vention; to have mixed effects when the results of 34% to
66% of the included studies favoured the intervention; or
to be generally ineffective when the results of fewer than
34% of the included studies favoured the intervention. If
there were fewer than five studies reporting on a specific
intervention outcome within a systematic review, we
considered this to be insufficient evidence to contribute to
our overall analysis of that intervention.Results
Results of the search
Figure 1 details the flow of information through the
different stages of this overview using the ‘preferred
reporting items for systematic reviews and meta-analyses’
(PRISMA) flow diagram [23]. Our searches resulted in
5,792 article citations. After the initial screening of titles
and abstracts, we retrieved 304 articles for full-text review.
Of these, we excluded 179 articles that did not meet the
eligibility criteria. The remaining 125 systematic reviews
were published in 76 journals between 1990 and 2011. We
assessed the methodological quality of these systematic re-
views and found a median AMSTAR score of 4 (interquar-
tile range, 2 to 6). Fifty systematic reviews were reported
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Figure 1 Flow chart of evidence from original source to final acceptance.
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AMSTAR score of 5 or more and were included in the
overview, and are described in Additional file 3
[16,17,24-75]. Details of the 75 excluded reviews are
provided in Additional file 4.
Description of systematic reviews included in analysis
Forty eight systematic reviews were published after
2000. All were published in English and originated from
Australia [37], Belgium [71], Canada [16,43,54,62,64,67],
China [49], Denmark [55], France [61], Germany [32],
the Netherlands [63,69,70], Norway [36], Saudi Arabia
[24], Switzerland [26], the United Kingdom [25,33,34,
39,40,44-47,50-53,65,66,68,72,73], and the United States
[27,28,30,31,35,38,42,56-60,74,75]. The number of includedstudies in each review ranged from five to eighty-two.
Thirty-one reviews restricted study design to include only
randomised controlled trials (RCTs) with or without con-
trolled clinical trials (CCTs) [24-28,31,33,34,36-38,42,44,46,
47,51-53,55,56,58,60,61,64-67,69,70,72,73]. In all but one
review that included other study designs, the predominant
study design adopted by the included primary studies was
the RCT. All reviews except four [16,34,38,50] used more
than one method of analysis and thirty-four reviews
used meta-analyses [16,24-28,30,31,33,36-40,42,44-47,
49,54-56,59-62,64,67,69-73]. Patient education and
support was the most common focus of the included
reviews (n = 21), followed by telemedicine (n = 10), broad
based reviews (n = 8), provider role changes (n = 7), and
organisational changes (n = 4) (Table 1).
Table 1 Description of included reviews by intervention category






Median no. of included studies
within reviews (min, max)
Patient education and support 21 8 (5, 11) 1990 to 2010 21 (5, 82)
Telemedicine 10 5.5 (5, 9) 2004 to 2011 20.5 (7, 44)
Provider role changes 7 7 (6, 9) 2003 to 2011 18 (5, 36)
Organisational changes 4 7.5 (6, 9) 1998 to 2011 7 (6, 23)
Broad based reviews 8 6 (5, 9) 2001 to 2011 41 (9, 58)
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type 2 diabetes or both [24,27,28,30,31,33,38,39,43-46,49,
51,52,54,56,57,59,61-64,68,70,74], five reviews considered
patients with type 1 diabetes only [32,35,65,67,72], and
16 focused only on type 2 diabetes [16,25,26,36,37,42,47,
50,53,55,58,60,66,69,71,73]. Two systematic reviews did
not specify the type of diabetes examined [40,75] and
one review addressed a range of chronic conditions that
included diabetes as an identifiable subset [31]. Interven-
tions were directed to specific populations or a combina-
tion of patients (including family and carers), providers,
and the healthcare system.
All but three reviews reported on glycaemic control in
patients [33,69,75]. Twenty systematic reviews reported
on changes in vascular risk factors (cholesterol, systolic
and diastolic blood pressure) [16,30,33,36,37,43,45,47,
52-54,57-60,63,66,70,71,74]. Ten systematic reviews re-
ported on optimal process of care goals [16,28,43,50,
57,58,63,69,71,75], with six reporting on HbA1c moni-
toring [16,28,50,57,63,71]. There was considerable hete-
rogeneity among the included primary studies in terms
of study designs, settings and interventions.Quality of systematic reviews included in the analysis
The majority of reviews met AMSTAR criterion relating
to the following: conducting a comprehensive search of
the literature (49/50); providing a list of the characte-
ristics of included studies (49/50); using appropriate
methods to combine the findings of the included studies
(48/50); assessing and documenting the scientific quality
of included studies (47/50), and using the results of the
scientific quality assessment in formulating conclusions
(38/50). However fewer studies met AMSTAR criteria
relating to the following: using independent reviewers
for selecting studies and extracting data (29/50); using
publication status as part of the inclusion criteria (25/50);
assessing the likelihood of publication bias (22/50);
providing an a priori design (21/50), and providing a list
of the included and excluded studies (18/50). Only one
review met the criteria for reporting conflict of interest of
review and studies (Table 2).Synthesis of broad based reviews
We identified eight systematic reviews evaluating the
effectiveness of a range of QI interventions directed to
one or more of patients, providers, and healthcare
systems (Additional file 3) [16,31,43,61,63,66,71,75].
Three reviews only included RCTs with or without
CCTs. Patient-directed interventions involved education
or information provision; [16,31,43,61,63,71], provider-
targeted interventions included the use of reminders or
prompts, educational materials, meetings, and outreach
[16,43,63,66,75]; system-targeted interventions included
changes in the physical structure of healthcare facilities,
introduction of health records systems or registries, and
changes to the site of service delivery [16,63,75]. Three
reviews examined the effectiveness of multiple ap-
proaches in specific patient populations: older adults
[31], socially disadvantaged groups [43], and minority
ethnic groups [66]. Among these reviews, we noted that
provider role changes such as role expansion and use of
multidisciplinary teams [16,31,43,61,63,66,71,75], and
telemedicine [16,43,63,75] interventions were frequently
evaluated. These reviews observed a number of likely
effective interventions. For example, Shojania and
colleagues [16,17] reviewed 66 studies (including 50 RCTs)
and 11 different QI interventions and observed a mean
reduction in HbA1c of 0.42%. Meta-regression identified
two interventions that were associated with HbA1c re-
ductions greater than 0.5%, team changes, and case
management.
Synthesis of results by intervention category
Patient education and support
Twenty-one systematic reviews examined the impact of
patient education and support interventions that help
patients and their families or carers understand diabetes
and its treatment by providing education and informa-
tion, emotional and behavioural support, coping strate-
gies, and self-management training [26,27,30,34-38,42,
45-47,52,53,55,58-60,65,69,72] (Additional file 3). The
majority of reviews only included RCTs with or without
CCTs (n = 17). Reviews varied in terms of the content
and variety of interventions, the target population, the
Table 2 AMSTAR score by QI category and individual systematic review












































Patient education and support
Allemann 2009 [26] y y y n y y y y y y n 9
Armour 2005 [27] n n y n n y y y y n n 5
Brown 1990 [30] n y y y n y y n y n n 6
Cooper 2009 [34] n n y y y y y y y n n 7
Couch 2008 [35] y y y y y y y y y y n 11
Deakin 2005 [36] y y y y y y y y y y n 10
Duke 2009 [37] y y y y y y y y y n n 9
Ellis 2004 [38] n y y y n y n n y y n 6
Gary 2003 [42] n n y y n n y y y y n 6
Hampson 2001 [45] y y y y n y y y y n n 8
Harkness 2010 [46] n n y n n y y n y y n 5
Hawthorne 2008 [47] y y y y y y y y y y y 11
Loveman 2003 [52] y n y y y y y y y n n 8
Loveman 2008 [53] y n y n y y y y y n n 7
Minet 2010 [55] n n y n n y y n y y n 5
Norris 2001 [58] n n y n n y y y y n n 5
Norris 2002 [59] y y y n y y y y y n n 8
Norris 2005 [60] y n y y y y y y y y n 9
Savage 2010 [65] n n y y n y y n y n n 5
Valk 2001 [69] y y y n y y y y y y n 9
Winkley 2006 [72] y y y y n y y y y y n 9
Total (n = 21) 12 11 21 13 11 20 20 16 21 11 1
Telemedicine
Balas 2004 [28] n n y y n y y y n n n 5
Farmer 2005 [39] n n y n n y y y y n n 5
Liang 2011 [49] n n y n n y y y y n n 5
Montori 2004 [56] y y y y n y n n y n n 6





















Table 2 AMSTAR score by QI category and individual systematic review (Continued)
Russell 2009 [64] n n y y n y y y n n n 5
Shulman 2010 [67] n y y y y y y y y n n 8
Sutcliffe 2011 [68] y n y y n y y y y n n 7
Verhoeven 2007 [70] n y y n n y y n y n n 5
Wu 2010 [73] y n y n y y y n y y n 7
Total (n = 10) 4 4 10 6 2 10 9 7 8 1 0
Provider role changes
Alam 2009 [25] y y n n n y y y y y n 7
Clark 2011 [33] n y y n n y y y y y n 7
Lindenmeyer 2006 [50] n y y y n y y y y n n 7
Loveman 2003 [51] y y y y y y y y y n n 9
Machado 2007 [54] n y y n n y y y y y n 7
Norris 2006 [57] y n y n n y y y y n n 6
Wubben 2008 [74] n y y n n y y y y n n 6
Total (n = 7) 3 6 6 2 1 7 7 7 7 3 0
Organisational
Al-Ansary 2011 [24] n y y y y y y n y n n 7
Clar 2007 [32] y y y n y y y y y y n 9
Foy 2010 [40] n y y n n y y y y y n 7
Griffin 1998 [44] n n y y n y y y y n n 6
Total (n =4) 1 3 4 2 2 4 4 3 4 2 0
Broad based reviews
Chodosh 2005 [31] n y y n n y y y y y n 7
Glazier 2006 [43] n y y n n y y n y n n 5
Pimouguet 2011 [61] n n y n y y y y y y n 7
Renders 2001 [63] n n y n n y y y y n n 5
Saxena 2007 [66] n y y y n y y n y n n 6
Shojania 2006 [16] n y y n n y n n y y n 5
Vermeire 2005 [71] n y y y y y y y y y n 9
Zhang 2007 [75] y n y n n y y y y y n 7
Total (n = 8) 1 5 8 2 2 8 8 5 8 5 0
* We awarded one point to each item that scored ‘yes’ (y) and summed these to calculate a total score; n, no.
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fied reviews evaluating tailored education packages
including culturally appropriate education [47], educa-
tion for adolescent diabetes patients [45], support for
children vs adults [72], individual vs group education
[36,37,42], and education delivered in the community,
home, recreational camps, and worksite [59]. The deli-
verers of patient education interventions, when specified,
were nurses (24.8%), dieticians (21.1%), physicians (16.6%),
psychologists (12.5%), multidisciplinary teams (8.0%),
diabetes educators (7.4%), specialist nurses (3.7%), or
others (5.9%). Four reviews did not specify who delivered
the intervention [26,27,34,65]. Changes in HbA1c levels in
patients were reported in all reviews, with one exception
[69]. Ten reviews reported on vascular risk factor control
in patients [30,36,37,45,47,52,53,58-60] and one review
focused on diabetic foot outcomes [69].
Overall, patient education and support interventions
were associated with improved glycaemic control for
patients of all ages in 18 reviews [26,27,30,35-38,42,
45-47,52,53,55,58-60,65,72], and with mixed results in
two reviews [60,72] (Table 3). Improved blood pressure
[36,52,53] and cholesterol [30,47,52,53,58] levels were
also associated with this intervention, though we noted
mixed results for blood pressure in one review [37] and
cholesterol in another [51]. A decrease in the occurrence
of diabetic foot outcomes such as ulcerations, infections,
and amputations was also associated with patient educa-
tion and support [69].
Telemedicine
We identified ten systematic reviews examining the
effectiveness of telemedicine technology in the provision
of diabetes care to local and remotely based patients
(Additional file 3) [28,39,49,56,62,64,67,68,70,73]. These
interventions consisted of the transmission of blood
glucose values by patients via phone (including mobile
or fax) and computer (Internet or website) to healthcare
providers for review, with feedback to patients by phone,
videoconference, or other electronic means. Seven
reviews only included RCTs with or without CCTs. Two
reviews addressed interventions targeted only to children
and young adults [67,68]. Three reviews described a sys-
tem interface where data were transmitted to a remote
server for analysis, after which appropriate automated
messages or reminders were sent to patients or their
providers [28,39,70].
All reviews reported on the clinical effectiveness of the
interventions on glycaemic control in patients. Telemedi-
cine interventions improved HbA1c levels in eight reviews
[28,49,56,64,67,68,70,73], and three reviews had mixed
results [39,62,70]. Where reviews examined different
modes of data transmission, it was found that SMS (short
message systems), when used alone or in conjunction withthe Internet to deliver home glucose records and support,
were generally associated with improved glycaemic con-
trol in patients [49,68]. Internet as a primary means of
transmission of blood glucose data and support also had a
positive effect on glycaemic control [68].
Provider role changes
Seven systematic reviews examined the effectiveness of
changing, expanding, or integrating the roles of healthcare
professionals to improve diabetes care and outcomes
(Additional file 3) [25,33,50,51,54,57,74]. Three reviews
only considered RCTs with or without CCTs. Five syste-
matic reviews examined the impact of role expansion by
increasing the responsibilities of pharmacists to include
medication management, patient education, and support
[50,54,74] and expanding the role of the nurse to include
educating and monitoring diabetes patients [33,51]. Other
provider role change interventions included role substitu-
tion and the use of multidisciplinary healthcare teams. In
one of these reviews, local community health workers
substituted for medical professionals or worked as part of
a multidisciplinary team to provide socioeconomic or
culturally appropriate care [57]. In a second review, general
practitioners substituted for psychological specialists [25].
All reviews reported on the clinical effectiveness of the
interventions on glycaemic control or vascular risk
factor control in patients. Interventions that involved
changing, expanding, or integrating the roles of health-
care professionals were associated with improvements
in patients’ glycaemic [25,50,51,54,57,74], cholesterol
[54,74], and blood pressure levels [33,54,74].
Organisational changes
Four systematic reviews examined the effectiveness of
organisational changes to improve diabetes management
and patient care (Additional file 3) [24,32,40,44]. Two
reviews only considered RCTs with or without CCTs.
Reviews compared the effectiveness of hospital vs home-
based [32] specialist or general practice care [44], point
of care testing for HbA1c at the time of patient consul-
tation [24], or shared decision making between primary
care physicians and specialists in patients receiving
ambulatory care [40]. The interventions in these syste-
matic reviews were heterogeneous and included the use
of patient/provider reminder systems, protocols, multi-
disciplinary teams, and interactive communication bet-
ween primary care physicians and specialists. One
review focused solely on outpatient paediatric popula-
tions [32]. Changes to patient HbA1c levels were the
only outcome reported in these systematic reviews.
The systematic reviews in this intervention category
had relatively few included studies and thus provided
insufficient evidence to allow us to determine if the
organisational changes were associated with improved
Table 3 Summary of results from included reviews on outcomes









Process Patient Process Patient Process Patient
Patient education and support
Allemann 2009 [26] 9 +
Armour 2005 [27] 5 +
Brown 1990 [30] 6 + + (Lipids), 0 (BP)
Cooper 2009 [34] 7 0
Couch 2008 [35] 10 +
Deakin 2005 [36] 10 + + (BP), 0 (Lipids)
Duke 2009 [37] 9 + Mixed (BP), O (Lipids) 0
Ellis 2004 [38] 6 +
Gary 2003 [42] 6 +
Hampson 2001 [45] 8 + 0 (Lipids)
Harkness 2010 [46] 5 +
Hawthorne 2008 [47] 11 + + (Lipids) 0 (BP)
Loveman 2008 [53] 7 + + (Lipids, BP)
Loveman 2003 [52] 8 + Mixed (Lipids) + (BP)
Minet 2010 [55] 5 +
Norris 2005 [60] 9 Mixed 0 (Lipids, BP)
Norris 2002 [59] 8 + 0 (Lipids, BP)
Norris 2001 [58] 5 + + (Lipids) 0 (BP) 0
Savage 2010 [65] 5 +
Valk 2001 [69] 9 *
Winkley 2006 [72] 9 Mixed
Telemedicine
Balas 2004 [28] 5 0 + 0 0
Farmer 2005 [39] 5 Mixed
Liang 2011 [49] 5 +
Montori 2004 [56] 6 +
Polisena 2009 [62] 8 Mixed
Russell 2009 [64] 5 +
Shulman 2010 [67] 8 +
Sutcliffe 2011 [68] 7 +
Verhoeven 2007 [70] 5 Mixed 0 (Lipids, BP)
Wu 2010 [73] 7 +
Provider role changes
Alam 2009 [25] 7 +
Clark 2011 [33] 7 Unclear + (BP)
Lindenmeyer
2006 [50] 7 0 + 0 0
Loveman 2003 [51] 9 +
Machado 2007 [54] 7 + + (Lipids, BP)
Norris 2006 [57] 6 0 + 0 (Lipids, BP)
Wubben 2008 [74] 6 + + (Lipids, BP)
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Table 3 Summary of results from included reviews on outcomes (Continued)
Organisational changes
Al-Ansary 2011 [24] 7 0
Clar 2007 [32] 9 0
Foy 2010 [40] 7 +
Griffin 1998 [44] 6 0
Broad based reviews
Chodosh 2005 [31] 6 +
Glazier 2006 [43] 5 + 0 (Lipids, BP) 0 0 0
Pimouguet 2011 [61] 7 +
Renders 2001 [63] 5 + + 0 0 (Lipids, BP) + 0 0
Shojania 2006 [16] 5 0 + 0 BP 0 0
Saxena 2007 [66] 6 + + (Lipids) mixed (BP)
Vermeire 2005 [71] 9 0 0 (Lipids, BP) 0
Zhang 2007 [75] 7 +
aAMSTAR score; +, generally effective based on n ≥ 5 comparisons; 0, insufficient comparisons to draw conclusions about effectiveness. *The Valk review reported
favourable patient outcomes that may reflect screening activities. See Additional file 3 for further details of this review. BP blood pressure.
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review included sufficient studies showing that shared
decision making between primary care physicians and
specialists improved blood glucose levels [40].Discussion
Summary of the evidence
In this overview, we identified 125 systematic reviews
that evaluated the effectiveness of quality improvement
interventions to improve diabetes care. We excluded 75
of these from further assessment due to low methodo-
logical quality and undertook a detailed analysis of 50
high quality reviews. The majority of included reviews
only considered RCTs with or without CCTs; in the
remaining reviews that included other designs, RCTs
and CCTs were the commonest designs included.
The eight broad based reviews examined a range of
different interventions that led to improvements in
patient self-management outcomes (glycaemic control
and cholesterol levels) and process of care behaviours
(HbA1c and retinopathy monitoring) with mixed results
for blood pressure control. Based on our assessment of
42 high quality intervention specific reviews, patient
education and support interventions were shown to
improve HbA1c, blood pressure, cholesterol, and diabetic
foot outcomes in patients; telemedicine interventions were
associated with improved glycaemic control in patients,
and provider role change interventions improved gly-
caemic and vascular risk factor control in patients. It was
unclear what impact organisational interventions had on
glycaemic control in patients. It was also unclear if there
was a relationship between the above four interventionsand improvements in monitoring of HbA1c, vascular risk
factors, or retinopathy, or diabetic foot outcomes. The
majority of reviews only included randomised trials alone
(with or without controlled clinical trials). In general, the
results and conclusions of the systematic reviews that only
included RCTs with or without CCTs were similar to
those including a broader range of designs. We were
unable to identify any high quality reviews that focussed
on other QI interventions relevant to our objectives, such
as financial or regulatory interventions.Strengths and weaknesses of the overview
Our objective was to synthesise a comprehensive body
of published evidence in a single overview. This is a
challenging undertaking considering that overview
methods are still evolving and a variety of approaches
are being used [20,76,77]. Strengths of our approach
include the use of explicit methods to identify, appraise
and summarise available systematic reviews of interven-
tions to improve diabetes management and outcomes.
We employed sensitive search strategies that were deve-
loped and run by an information specialist with expertise
in searching for interventions to improve health care
delivery and healthcare systems. Two authors indepen-
dently undertook study selection, quality appraisal using
the validated AMSTAR tool, and data abstraction with a
consensus process to address disagreements. Further, we
performed a reanalysis of the results of reviews using
vote-counting to ensure consistency of analytical ap-
proach when considering results across the reviews. We
focussed on high quality reviews (any review scoring ≥5
on AMSTAR) as our previous experience suggested that
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pret and likely do not provide reliable evidence. Our
approach allowed us to explore whether different review
teams addressing similar review questions independently
observe similar results and draw broadly similar con-
clusions. The consistency of findings and conclusions
across high quality reviews, for example that patient
education and support improves many aspects of
diabetes care, suggests that this is not likely a spurious
finding due to the review team or methods chosen.
However, overviews inevitably suffer from potential
weaknesses, some of which are common to all synthesis
projects and others that are specific to overviews. Poten-
tial weaknesses that are common to all syntheses include
the possibility that our searches missed relevant reviews, or
that errors were made during study selection, quality
appraisal and data collection. Overview-specific weaknesses
relate to the fact that our unit of study is a completed
systematic review. Thus, overview authors are dependent
upon the methods of the included systematic reviews that
potentially suffer from some of the common weaknesses
mentioned above. Overviews that consider multiple re-
views on the same topic potentially protect against weak-
nesses in individual reviews unless all included reviews
share precisely the same methodological weakness. In our
overview we also tried to minimise the likelihood that we
would be misled by individual reviews by excluding low
quality reviews that are more likely to suffer to from major
methodological weaknesses.
Overviews are also dependent on the reporting of the
included systematic reviews, which limits the granularity
of detail available to the overview author. As a result,
the overview author needs to trust the systematic review
authors' quality appraisal and data abstraction and is
limited by the level of detail in the original systematic
reviews when describing characteristics of included
studies such as setting, and intervention, etcetera. As
well, overviews are limited by the coverage of the identi-
fied systematic reviews. For instance, there has been
increasing interest in the use of financial interventions
to improve diabetes care; the United Kingdom intro-
duced a pay-for-performance incentive program in 2004,
rewarding family practices for achieving performance
targets in chronic disease management, including
diabetes [78]. However, despite this policy interest and
the availability of primary studies, we were unable to
find any high quality systematic reviews that addressed
the effects of financial interventions on quality of
diabetes care. Finally, overview authors should expect
considerable overlap in the primary studies summarised
in the included systematic reviews. As a result it is
important not to treat systematic reviews as independent
observations but rather see included systematic reviews
as a different lens addressing the same question todetermine whether different teams draw broadly similar
conclusions.
The interventions examined in these reviews were
frequently complex. Reporting of complex interventions
is often poor in primary studies [79] and even poorer in
systematic reviews that may reduce a short description
in a primary study to a few words in a table. This creates
a number of difficulties for overview authors; whilst
overview authors might be confident that a review does
address the overview question frequently, there will be
insufficient detail within the review to be able to
describe the evaluated reviews in detail, or to determine
effective components of complex interventions, or
explore potential effect modifiers.
Within our overview, we reanalysed the included
reviews using vote counting based on direction of effect.
The weaknesses of vote counting are well documented
and include the failure to provide an estimate of the
effect size of an intervention, failure to take into account
the precision of the estimate from the primary compari-
sons, and giving equal weight to comparisons with 100
or 1,000 participants [22]. Nevertheless, we would argue
that vote counting provided a flexible approach to con-
sider effectiveness across reviews with few assumptions
given that the included reviews involved different study
designs, presented individual study reviews using diffe-
rent metrics and used a variety of analytical approaches
(including descriptive analysis, vote-counting, meta-
analysis and meta-regression). To increase the confidence,
we reported separately, the number of RCTs that contrib-
uted to the overall effect for each intervention comparison.
Further, we also reported the results of any meta-analyses
performed in the reviews that had bearing on the interven-
tions and outcomes of interest.
Implications for policy
Overviews are high-level syntheses of research evidence
that provide an evidence map for decision makers and
high-level conclusions about an issue. However, it is
likely that decision makers will also need to consult
some of the included systematic reviews, and potentially
the individual studies, to address their specific questions.
Thus, this synthesis is best seen as an entry point to
evidence to inform healthcare decision makers' policy op-
tions about interventions to improve diabetes outcomes.
Current initiatives to improve diabetes management and
care should be informed by this evidence base. There is
consistent evidence that a number of interventions, for
example, patient education and support, telemedicine, and
provider role changes, appear to improve diabetes quality
of care, and policy-makers need to consider whether their
current services optimally provide these effective inter-
ventions to their population of persons with diabetes.
Overall, there is some evidence to suggest that tailoring
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beneficial to the effectiveness of the treatment strategy.
Interventions at an organisational level had insufficient
evidence from which to draw conclusions about their
effectiveness, and therefore policy makers should be
cautious about implementing these approaches until
further evidence is available.
Implications for research
There is a considerable body of evidence evaluating
interventions to improve diabetes care that should
inform future research. Researchers conducting both
primary studies and systematic reviews of diabetes qual-
ity improvement interventions should consider the
breadth of outcomes relevant to excellent diabetes care.
In areas with a substantial number of trials demonstrat-
ing benefit, for instance, patient education and support,
future research should focus on direct comparisons of
different delivery methods for the same intervention or
of direct comparisons of the relative effectiveness of
different interventions.
The results of available systematic reviews should
inform the choice and design of evaluated interventions
and evaluative methods. For example, new systematic
reviews of diabetes QI interventions might focus on
interventions where there are few or no current system-
atic reviews. Patient education provides an example of a
group of interventions where the depth and quality of
the evidence is abundant and where further reviews may
add little to our knowledge unless they address second-
ary questions such as how to optimise or extend the
reach of patient education and support interventions.
While we identified some evidence of attempts by
researchers to separate the effects of complex interven-
tions, future studies should further focus on such sepa-
ration in order to provide specific advice on how to
optimise efforts to improve diabetes management. Given
our observation that 60% of the reviews assessed for this
project were rejected based on low AMSTAR scores,
researchers are strongly encouraged to consider AMSTAR
assessment criteria during the systematic reviewing
process in order to improve the methodological quality
and/or reporting of their work.
Conclusions
Overviews provide high-level summaries of empirical
research. This overview identified and summarised the
best current available evidence from 125 systematic
reviews on the effectiveness of different QI interventions
to improve diabetes care. The results suggest that
patient education and support, provider role changes
and telemedicine are associated with improved patient
outcomes. They can be used by decision makers to iden-
tify policy options to improve diabetes care and as asource document to identify systematic reviews and indi-
vidual studies that are relevant to their context and that
address their specific questions. It also identified poten-
tial areas for future research; highlighting the problem of
(likely) inappropriate duplication of effort between
existing systematic reviews and the lack of high-quality
systematic reviews addressing interventions of policy
interest, such as regulatory or financial interventions.
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